Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?

doi:10.3748/wjg.v25.i27.3563

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6417)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

462

HTML

3624

Figures (1-1)

267

Tables (1-1)

214

Sum=4567

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

849

Download

1001

Sum=1850

Jul 21, 2019 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jul 21, 2019; 25(27): 3563-3571
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3563

Open in New Tab Full Size Figure Download Figure

Figure 1 Schematic diagram–risk-benefit profile comparing aged patients with young patients in hepatocellular carcinoma treatments. TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation; SR: Surgical resection; LT: Liver transplantation; HCC: Hepatocellular carcinoma.

Citation: Chu KKW, Chok KSH. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients? World J Gastroenterol 2019; 25(27): 3563-3571
URL: https://www.wjgnet.com/1007-9327/full/v25/i27/3563.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i27.3563